Aplidin (plitidepsin)

DRUG2 trials

Sponsors

PharmaMar

Conditions

MyelofibrosisProstate Cancer

Phase 2

A Study of Aplidin ( Plitidepsin) in Subjects With Advanced Prostate Cancer

TerminatedNCT00780975

PharmaMarProstate Cancer

Start: 2005-02-28End: 2008-03-31Updated: 2020-11-24

Clinical Trial of Aplidin® in Patients With Primary Myelofibrosis

CompletedNCT01149681

PharmaMarMyelofibrosis

Start: 2010-07-31End: 2011-02-28Updated: 2020-10-12